menu
    • menu

    Company profile for Tavanta Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tavanta is a clinical stage specialty pharmaceutical company developing a diverse pipeline of specialty drugs that bring clinically meaningful benefits to patients with serious or debilitating diseases. Tavanta Therapeutics (reorganized from Druggability Technologies) is a global organization with corporate headquarters in the greater Philadelphia area and a research and development facility in Budapest, Hungary. Through thes...
    Tavanta is a clinical stage specialty pharmaceutical company developing a diverse pipeline of specialty drugs that bring clinically meaningful benefits to patients with serious or debilitating diseases. Tavanta Therapeutics (reorganized from Druggability Technologies) is a global organization with corporate headquarters in the greater Philadelphia area and a research and development facility in Budapest, Hungary. Through these global centers, the company is geographically located to utilize experienced local talent for research, development, and commercialization of new therapeutic options for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tavanta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1000 First Avenue, Suite 405 King of Prussia, PA 19406
    Telephone
    Telephone
    +1 610 424 2795
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tavanta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tavanta/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tavanta Therapeutics to Showcase Specialty Pipeline During the 2023 ASCO
    Tavanta Therapeutics to Showcase Specialty Pipeline During the 2023 ASCO

    31 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tavanta-therapeutics-to-showcase-specialty-pipeline-during-the-2023-american-society-of-clinical-oncology-asco-and-american-society-of-colon-and-rectal-surgeons-ascrs-annual-congresses-301838071.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    Tavanta Announces New Data for its Cystic Fibrosis Candidate TAVT-135
    Tavanta Announces New Data for its Cystic Fibrosis Candidate TAVT-135

    24 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tavanta-therapeutics-announces-new-preclinical-data-for-its-cystic-fibrosis-candidate-tavt-135-at-two-prominent-scientific-conferences-301832965.html

    PR NEWSWIRE
    24 May 2023
    Share Share
    Tavanta Announces Positive Top-line Results from Pivotal Phase 3 Trial
    Tavanta Announces Positive Top-line Results from Pivotal Phase 3 Trial

    05 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tavanta-therapeutics-announces-positive-top-line-results-from-pivotal-phase-3-trial-of-tavt-45-for-the-treatment-of-metastatic-prostate-cancer-301714563.html

    PR NEWSWIRE
    05 Jan 2023
    Share Share
    Tavanta Therapeutics to Present Preclinical Data for TAVT-135
    Tavanta Therapeutics to Present Preclinical Data for TAVT-135

    28 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/tavanta-therapeutics-to-present-preclinical-data-for-tavt-135-at-the-north-american-cystic-fibrosis-conference-301662485.html

    PRNEWSWIRE
    28 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search